{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:12:12Z","timestamp":1784013132935,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00277-024-05871-0","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T01:01:25Z","timestamp":1720054885000},"page":"2983-2991","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of additional cytogenetic aberrations at diagnosis on prognosis of adults patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: a retrospective analysis"],"prefix":"10.1007","volume":"103","author":[{"given":"Jing","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huarui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"key":"5871_CR1","doi-asserted-by":"crossref","unstructured":"Chiaretti S, Vitale A, Cazzaniga G et al (2013) Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. Haematologica 98: 1702\u20131710","DOI":"10.3324\/haematol.2012.080432"},{"key":"5871_CR2","doi-asserted-by":"crossref","unstructured":"Jabbour E, Pui C-H, Kantarjian H (2018) Progress and innovations in the management of adult acute lymphoblastic leukemia. JAMA Oncol 4:1413\u20131420","DOI":"10.1001\/jamaoncol.2018.1915"},{"key":"5871_CR3","doi-asserted-by":"crossref","unstructured":"Soverini S, Bassan R, Lion T (2019) Treatment and monitoring of Philadelphia chromosome-positive leukemia patients: recent advances and remaining challenges. J Hematol Oncol 12:39","DOI":"10.1186\/s13045-019-0729-2"},{"key":"5871_CR4","doi-asserted-by":"crossref","unstructured":"Short NJ, Kantarjian H Jabbour E (2012) Optimizing the treatment of acute lymphoblastic leukemia in younger and older adults: new drugs and evolving paradigms. Leukemia 35:3044\u20133058","DOI":"10.1038\/s41375-021-01277-3"},{"key":"5871_CR5","doi-asserted-by":"crossref","unstructured":"Soverini S, Albano F, Bassan R et al (2020) Next-generation sequencing for BCR-ABL1 kinase domain mutations in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a position paper. Cancer Med 9:2960\u20132970","DOI":"10.1002\/cam4.2946"},{"key":"5871_CR6","doi-asserted-by":"crossref","unstructured":"Nishiwaki S, Kim JH, Ito M et al (2020) Multi-lineage BCR-ABL expression in Philadelphia chromosome-positive Acute Lymphoblastic Leukemia is Associated with Improved Prognosis but no specific molecular features. Front Oncol 10:586567","DOI":"10.3389\/fonc.2020.586567"},{"key":"5871_CR7","doi-asserted-by":"crossref","unstructured":"Arana Trejo RM, Del CMA, Alcal\u00e1 Carmona LG et al (2016) Chromosomal abnormalities in patients with haematologic malignancies in the general hospital of Mexico. Revista M\u00e9dica Del Hosp Gen De M\u00e9xico 80:87\u201391","DOI":"10.1016\/j.hgmx.2016.11.006"},{"key":"5871_CR8","doi-asserted-by":"crossref","unstructured":"Awan UA, Farooq N, Sarwar A et al (2021) Cytogenetic abnormalities in patients with hematological malignancies in Lahore city, Pakistan. Braz J Biol 83: e249911","DOI":"10.1590\/1519-6984.249911"},{"key":"5871_CR9","doi-asserted-by":"crossref","unstructured":"Dombret H, Gabert J, Boiron JM et al (2002) Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia\u2013results of the prospective multicenter LALA-94 trial. Blood 100:2357\u20132366","DOI":"10.1182\/blood-2002-03-0704"},{"key":"5871_CR10","doi-asserted-by":"crossref","unstructured":"Wetzler M, Dodge RK, Mrozek K et al (2004) Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B. Br J Haematol 124:275\u2013288","DOI":"10.1046\/j.1365-2141.2003.04736.x"},{"key":"5871_CR11","doi-asserted-by":"crossref","unstructured":"Schultz KR, Carroll A, Heerema NA et al (2014) Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: children\u2019s Oncology Group study AALL0031. Leukemia 28:1467\u20131471","DOI":"10.1038\/leu.2014.30"},{"key":"5871_CR12","doi-asserted-by":"crossref","unstructured":"Short NJ, Kantarjian HM, Sasaki K et al(2017) Poor outcomes associated with +\u2009Der(22)t(9;22) and \u2013\u20099\/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor. Am J Hematol 92:238\u2013243","DOI":"10.1002\/ajh.24625"},{"key":"5871_CR13","doi-asserted-by":"crossref","unstructured":"Aldoss I, Stiller T, Cao TM et al (2015) Impact of additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive Acute Lymphoblastic Leukemia undergoing allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transpl 21:1326\u20131329","DOI":"10.1016\/j.bbmt.2015.03.021"},{"key":"5871_CR14","doi-asserted-by":"crossref","unstructured":"Gonzalez Garcia JR, Meza-Espinoza JP (2006) Use of the International System for Human Cytogenetic nomenclature (ISCN). Blood 108:3952\u20133953","DOI":"10.1182\/blood-2006-06-031351"},{"key":"5871_CR15","doi-asserted-by":"crossref","unstructured":"Malakzai HA, Rahmani S, Haidary AM et al (2020) Complex cytogenetic abnormalities in chronic myeloid leukemia resulting in early progression to blast crisis: a case report. J Med Case Rep 14:231","DOI":"10.1186\/s13256-020-02539-x"},{"key":"5871_CR16","doi-asserted-by":"crossref","unstructured":"Ansari S, Verma M (2023) Control of Ph\u2009+\u2009and additional chromosomal abnormalities in chronic myeloid leukemia by tyrosine kinase inhibitors. Med Oncol 40: 237","DOI":"10.1007\/s12032-023-02116-4"},{"key":"5871_CR17","doi-asserted-by":"crossref","unstructured":"Johansson B, Fioretos T, Mitelman F (2002) Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 107:76\u201394","DOI":"10.1159\/000046636"},{"key":"5871_CR18","doi-asserted-by":"crossref","unstructured":"Mitelman F, Levan G, Nilsson PG et al (1976) Non-random karyotypic evolution in chronic myeloid leukemia. Int J Cancer 18:24\u201330","DOI":"10.1002\/ijc.2910180105"},{"key":"5871_CR19","doi-asserted-by":"crossref","unstructured":"Hehlmann R, Voskanyan A, Lauseker M et al (2020) High-risk additional chromosomal abnormalities at low blast counts herald death by CML. Leukemia 34(8): 2074\u20132086","DOI":"10.1038\/s41375-020-0826-9"},{"key":"5871_CR20","doi-asserted-by":"crossref","unstructured":"Bonifacio M, Elena C, Mariella DA et al (2020) Do not Miss Karyotyping at Chronic myeloid leukemia diagnosis: an Italian campus CML Study on the role of complex variant translocations. Blood 136:43\u201344","DOI":"10.1182\/blood-2020-139826"},{"key":"5871_CR21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/cncr.30376","volume":"123","author":"GC Issa","year":"2017","unstructured":"Issa GC, Kantarjian HM, Yin CC et al (2017) Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease. Cancer 123:459\u2013467","journal-title":"Cancer"},{"key":"5871_CR22","doi-asserted-by":"crossref","unstructured":"Moorman AV, Harrison CJ, Buck GA et al (2007) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 109:3189\u20133197","DOI":"10.1182\/blood-2006-10-051912"},{"key":"5871_CR23","doi-asserted-by":"crossref","unstructured":"Akahoshi Y, Mizuta S, Shimizu H et al (2018) adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Additional cytogenetic abnormalities with Philadelphia chromosome-positive Acute Lymphoblastic Leukemia on allogeneic stem cell transplantation in the tyrosine kinase inhibitor era. Biol Blood Marrow Transpl 24: 2009\u20132016","DOI":"10.1016\/j.bbmt.2018.06.006"},{"key":"5871_CR24","unstructured":"Thomas X, Thiebaut A, Olteanu N et al (1998) Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome. Hematol Cell Ther 40:119\u2013128"},{"key":"5871_CR25","doi-asserted-by":"crossref","unstructured":"Gorre ME, Mohammed M, Ellwood K et al (2001) clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293:876\u2013880","DOI":"10.1126\/science.1062538"},{"key":"5871_CR26","doi-asserted-by":"crossref","unstructured":"Hochhaus A, Kreil S, Corbin AS et al (2002) Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. Leukemia 16:2190\u20132196","DOI":"10.1038\/sj.leu.2402741"},{"key":"5871_CR27","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1182\/blood-2016-01-690230","volume":"127","author":"W Wang","year":"2016","unstructured":"Wang W, Cortes JE, Tang G et al (2016) Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood 127:2742","journal-title":"Blood"},{"key":"5871_CR28","unstructured":"Zhao HF, Zhang Y, Zu YL et al (2019) The influence of additive clonal chromosome abnormalities in Ph negative cells on the efficacy of chronic myeloid leukemia. Zhonghua Nei Ke Za Zhi 58:803\u2013807"},{"key":"5871_CR29","doi-asserted-by":"crossref","unstructured":"Heerema NA, Nachman JB, Sather HN et al (2004) Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children\u2019s Cancer Group. Leukemia 18:939\u2013947","DOI":"10.1038\/sj.leu.2403327"},{"key":"5871_CR30","doi-asserted-by":"crossref","unstructured":"Rieder H, Ludwig WD, Gassmann W et al?1996?Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia. Br J Haematol 95:678\u2013691.","DOI":"10.1046\/j.1365-2141.1996.d01-1968.x"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05871-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05871-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05871-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T02:11:09Z","timestamp":1722046269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05871-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["5871"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05871-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4223756\/v1","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,4]]},"assertion":[{"value":"5 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}